Dicot Pharma AB (STO:DICOT)

Dicot Pharma AB Balance Sheet

Financials in millions SEK. Fiscal year is January - December.

Fiscal Year	TTM	FY 2024	FY 2023	FY 2022	FY 2021	FY 2020
Period Ending	Sep 30, 2025	Dec 31, 2024	Dec 31, 2023	Dec 31, 2022	Dec 31, 2021	Dec 31, 2020
Cash & Equivalents	90	113.42	47.34	9.38	30.33	20.33
Cash & Short-Term Investments	90	113.42	47.34	9.38	30.33	20.33
Cash Growth	-30.98%	139.58%	404.88%	-69.08%	49.20%	66.30%
Other Receivables	3.5	3.47	2.3	1.14	1.01	0.9
Receivables	3.5	3.47	2.3	1.14	1.01	0.9
Inventory	7.4	5.38	3.4	1.49	-	-
Prepaid Expenses	-	1.35	0.5	0.34	0.4	0.34
Other Current Assets	-	-	-0	-	-	-
Total Current Assets	100.9	123.62	53.54	12.35	31.74	21.57
Property, Plant & Equipment	-	-	0.01	0.02	0.03	0.04
Total Assets	100.9	123.62	53.56	12.37	31.77	21.61
Accounts Payable	-	6.84	4.54	3.42	2.58	1.49
Accrued Expenses	-	4.05	3.98	1.19	0.66	0.37
Other Current Liabilities	10.6	1.07	0.64	2.41	0.19	0.09
Total Current Liabilities	10.6	11.96	9.16	7.01	3.42	1.95
Total Liabilities	10.6	11.96	9.16	7.01	3.42	1.95
Common Stock	14.1	12.45	5.72	17.14	12.86	5.46
Additional Paid-In Capital	-	299	180.76	86.15	81.67	53.2
Retained Earnings	-	-199.79	-142.09	-97.93	-66.18	-39
Shareholders' Equity	90.3	111.67	44.39	5.36	28.35	19.66
Total Liabilities & Equity	100.9	123.62	53.56	12.37	31.77	21.61
Net Cash (Debt)	90	113.42	47.34	9.38	30.33	20.33
Net Cash Growth	-30.98%	139.58%	404.88%	-69.08%	49.20%	66.30%
Net Cash Per Share	0.05	0.10	0.09	0.08	0.47	0.71
Filing Date Shares Outstanding	2,009	1,779	817.56	137.1	102.9	43.67
Total Common Shares Outstanding	2,009	1,779	817.56	137.1	102.9	43.67
Working Capital	90.3	111.67	44.38	5.34	28.32	19.62
Book Value Per Share	0.01	0.06	0.05	0.04	0.28	0.45
Tangible Book Value	14.1	111.67	44.39	5.36	28.35	19.66
Tangible Book Value Per Share	0.01	0.06	0.05	0.04	0.28	0.45
Machinery	-	-	0.04	0.04	0.04	0.04

Updated Sep 30, 2025. Source: S&P Global Market Intelligence. Standard template. Financial Sources.